Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Right to Learn cyclists still solid on the pedals
2017-11-29


  Description: Right to Learn cyclists Tags: UFS Right to Learn, Given and Gain, Cape Town, Prof Nicky Morgan, Asive Dlanjwa, students, cycling, Qwaqwa, Bloemfontein

Asive Dlanjwa, Bloemfontein Campus SRC President, on the
morning of their departure from Bloemfontein.
Photo: Nhlanhla Modzanane


It is a new day and the Right to Learn cycling team continues to make its way to Cape Town.The team arrived at their first stop in Luckhoff on day one, after cycling for 182 kilometres in five hours and five minutes. They left Luckhoff at 05:00 in the morning on day two, heading towards Britstown via De Aar and arrived at midday. On day three, the team will rest in Britstown and will continue cycling on day four, 30 November 2017, to Victoria West for 133 kilometres via Merriman.

Looking forward to another day
Asive Dlanjwa, Bloemfontein Campus SRC President, felt confident about day two despite the strong winds that they experienced along the way. “I’m feeling strong, I actually thought after day one that I’ll be feeling a bit weak, but I just don’t know how we are going to make it in this wind,” he says. Dlanjwa and his fellow cyclists cycled for 213 kilometres to Britstown, where they ended their race for day two. 

Kovsies fully behind cycling team

The tour began on 27 November 2017 in Bloemfontein, when they were sent off by Prof Nicky Morgan, former Vice-Rector: Operations, Pura Mgolombane, Dean of Student Affairs, and their Kovsie peers. Prof Morgan encouraged the team to have a wonderful and enjoyable journey, acknowledging that the journey will not be an easy one. “I want you to know that you have the support of everyone here at the UFS,” he said.
 
Messages of support continue to pour in for the team on the UFS social media platforms. The Qwaqwa Campus SRC President, Hlalele Masopha, also sent his best wishes to his mate, saying, “I wish the President with his crew a quantity of good fortune and extremely good success.” He says, “This is for the betterment of the students and the institution.”  

There have been no reports of any injuries or medical defects incurred by the cyclists nor the supporting team who are travelling with them. The team is expected to arrive in Cape Town on 4 December 2017.  

You can make a donation as follows: 

Give-n-gain page

 

EFT transaction:
Please use the following bank details:
Bank: ABSA Bank
Account Number: 1570850721
Branch Code: 632005
Account Type: Cheque
Reference: R2L: Right to Learn
Send the proof of payment Rinda Duraan: duraanmj@ufs.ac.za

Debit order: Download the form and email it to Rinda Duraan

All donations are tax deductible in terms of South African income tax legislation.  


Related article:

27 November: Kovsies SRC President cycles to raise money for registration


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept